12-109768347-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032829.3(FAM222A):c.418G>A(p.Ala140Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000696 in 1,595,550 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032829.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM222A | NM_032829.3 | c.418G>A | p.Ala140Thr | missense_variant | 3/3 | ENST00000538780.2 | NP_116218.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM222A | ENST00000538780.2 | c.418G>A | p.Ala140Thr | missense_variant | 3/3 | 1 | NM_032829.3 | ENSP00000443292.1 | ||
FAM222A | ENST00000358906.3 | c.418G>A | p.Ala140Thr | missense_variant | 3/3 | 5 | ENSP00000351783.3 | |||
FAM222A-AS1 | ENST00000541460.2 | n.189+4950C>T | intron_variant | 4 | ||||||
FAM222A-AS1 | ENST00000541723.5 | n.212+4950C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000202 AC: 43AN: 212688Hom.: 0 AF XY: 0.000179 AC XY: 21AN XY: 117632
GnomAD4 exome AF: 0.0000707 AC: 102AN: 1443214Hom.: 0 Cov.: 31 AF XY: 0.0000767 AC XY: 55AN XY: 717428
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at